fda bpc-157 compounding safety concerns The U.S. Food and Drug Administration is moving toward allowing pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant risks, the New York BPC-157: The peptide with big
Description
After reconstitution, refrigerate the vial

Inloes, J

BPC-157 + Recovery Supplements Peptides work best when supported by a strong nutritional and antioxidant foundation

Sub q should in theory give close to 100% bioavailability, but we really dont know the one PK study never tested it, so theres no measured number and no dosing conversion behind it
